In response to the market demand, Indian drugmakers, including Cipla, are actively developing generic versions of these weight-loss drugs to secure a larger market ... May 13
The awards ceremony also featured insightful keynote addresses, panel discussions, and networking opportunities, providing attendees with valuable insights and opportunities for collaboration.... Apr 27
Biocon's foray into the weight-loss drug market aligns with its significant investment in generics research and development, with a notable focus on peptides ... Apr 20
While Sanofi India will continue to own, import, and manufacture its complete range of CNS products across plants in India and internationally, Cipla will leverage ... Mar 26
By working together to address this grave threat, we can uphold the integrity of the pharmaceutical industry and protect the health and safety of individuals ... Mar 07
et us all join hands to shape a future that is not only economically prosperous but also socially equitable and environmentally sustainable: Meela Jayadev, FTCCI ... Jan 30
In the 1920s, an affluent father wanted his son to become a barrister. But the son chose to pursue chemistry instead. Learn the incredible story ... Sep 17
Imagine the year 1969. In our domestic pharmaceutical market, Indian companies had a share of a mere 5%. Cut to last year where they had ... Sep 16
With over 4800 e-pharmacy active companies in India, will Netmed, the earliest venture of online pharmacy still survive and beat the severe competition raised ... Aug 04
Can doctors be business owners? When actors and cricketers can become business owners, then why not doctors? Once a doctor, always a doctor. When there ... Jul 01
Brovana® is a long-acting beta-2 adrenergic agonist (beta-2 agonist) indicated for treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), ... Jun 23
... May 25
... Mar 26
... Mar 15
Top ten pharma stocks January 2021... Jan 06
CIPtest is a reliable high-performing kit that has been validated and approved by ICMR.... Dec 16
Cipla wins the litigation case against Bristol Myers Squibb... Dec 12
WHO starts Commit to quit campaign for World No Tobacco Day 2021... Dec 12
Bristol Myers Squibb today announced that its wholly-owned subsidiary, Celgene, and Cipla have settled their litigation related to patents for REVLIMID.... Dec 11
WHO today launches a year-long global campaign for World No Tobacco Day 2021 - “Commit to Quit."... Dec 09
Cipla today announced that it signed a licensing agreement with a Belgium-based firm, Multi G for the distribution of their COVID-19 Rapid Antibody ... Nov 20
Cipla will be responsible for the marketing and distribution of the SARS CoV-2-IgG antibody detection ELISA that will be manufactured by KARWA Ltd.... Oct 28
Cipla Limited today announced that it has launched generic Nintedanib for the treatment of Idiopathic Pulmonary Fibrosis ... Oct 21
Cipla Limited today announced that it has received final approval for its ANDA for Dimethyl Fumarate Capsules... Sep 25
Coronavir's approval as a prescription drug follows the green light for another Russian COVID-19 drug, Avifavir, in May... Sep 19
-Advertisements-
Saturday, June 01, 2024
.jpg)
